Uncommon Finding of a Gastrointestinal Stromal Tumor in a Patient with Hyperechoic Liver Lesions - Case Report

1. Liu J, Wang D, Li H, et al - Clinical value of contrast-enhanced ultrasound in diagnosis of hyperechoic liver lesions. Med Sci Monit. 2015; 21:284510.12659/MSM.894115Search in Google Scholar

2. Casali PG, Blay JY - ESMO/CONTICANET/EUROBONET Consensus Panel of Experts. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21:98-10210.1093/annonc/mdq208Search in Google Scholar

3. Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR - Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiol. 2016; 40:39-4610.1016/j.canep.2015.10.031Search in Google Scholar

4. Wozniak A, Rutkowski P, Piskorz A, et al - Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience. Ann Oncol. 2011; 23:353-36010.1093/annonc/mdr127Search in Google Scholar

5. Ducimetière F, Lurkin A, Ranchere-Vince D, et al - Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PloS one. 2011; 6: e20294.10.1371/journal.pone.0020294Search in Google Scholar

6. Hechtman JF, DeMatteo R, Nafa K, et al - Additional primary malignancies in patients with gastrointestinal stromal tumor (GIST): a clinicopathologic study of 260 patients with molecular analysis and review of the literature. Ann Surg Oncol. 2015; 22:2633-39.10.1245/s10434-014-4332-zSearch in Google Scholar

7. D’Onofrio M, Crosara S, De Robertis R, Canestrini S, Mucelli RP - Contrast-enhanced ultrasound of focal liver lesions. AJR Am J Roentgenol. 2015; 205: W56-W6610.2214/AJR.14.14203Search in Google Scholar

8. Hohmann J, Muller A, Skrok J, et al - Detection of hepatocellular carcinoma and liver metastases with BR14: a multicenter phase IIA study. Ultrasound Med Biol. 2012; 37: 377-382.10.1016/j.ultrasmedbio.2011.11.018Search in Google Scholar

9. Claudon M, Dietrich CF, Choi BI, et al - Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2013; 39: 187-210.10.1016/j.ultrasmedbio.2012.09.002Search in Google Scholar

10. Nishida T - The Role of Endoscopy in the Diagnosis of Gastric Gastrointestinal Stromal Tumors. Ann Surg Oncol. 2015; 22: 2810-2811.10.1245/s10434-015-4520-5Search in Google Scholar

11. Watson RR, Binmoeller KF, Hamerski CM, et al - Yield and performance characteristics of endoscopic ultrasound-guided fine needle aspiration for diagnosing upper GI tract stromal tumors. Dig Dis Sci. 2011; 56: 1757-1762.10.1007/s10620-011-1646-6Search in Google Scholar

12. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M - CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998; 11: 728-734Search in Google Scholar

13. West RB, Corless CL, Chen X, et al - The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors, irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004; 165: 107-13.10.1016/S0002-9440(10)63279-8Search in Google Scholar

14. Shi YN, LI Y, Wang LP, et al - Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China. Medicine. 2017; 96: e8240.10.1097/MD.0000000000008240570478529145240Search in Google Scholar

15. Abuzakhm SM, Acre-Lara CE, Zhao W, et al. Unusual metastases of gastrointestinal stromal tumor and genotypic correlates: Case report and review of the literature. J Gastrointest Oncol. 2011, 2.1: 45Search in Google Scholar

16. Burkill GJC, Badran M, Al-Muderis O, et al. Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. Radiology, 2003; 226.2: 527-532.10.1148/radiol.226201188012563150Search in Google Scholar

17. Blanke CD, Demetri GD, von Mehren M, et al - Long-term results from a randomized phase II trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol. 2008; 26: 620–25.10.1200/JCO.2007.13.440318235121Search in Google Scholar

18. Blanke CD, Rankin C, Demetri GD, et. al - Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol. 2008; 26: 626–32.10.1200/JCO.2007.13.445218235122Search in Google Scholar